Nikko Asset Management Americas Inc. continued to hold its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,000 shares of the pharmacy operator’s stock at the close of the 2nd quarter. Nikko Asset Management Americas Inc.’s holdings in Walgreens Boots Alliance were worth $157,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Reilly Financial Advisors LLC boosted its position in Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after acquiring an additional 100 shares during the last quarter. Orrstown Financial Services Inc. boosted its position in Walgreens Boots Alliance by 14.1% during the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after acquiring an additional 213 shares during the last quarter. MCF Advisors LLC boosted its position in Walgreens Boots Alliance by 68.2% during the first quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock valued at $160,000 after acquiring an additional 780 shares during the last quarter. Founders Capital Management bought a new stake in Walgreens Boots Alliance during the first quarter valued at $161,000. Finally, Signature Estate & Investment Advisors LLC bought a new stake in Walgreens Boots Alliance during the first quarter valued at $197,000. 60.16% of the stock is currently owned by institutional investors and hedge funds.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 67.56 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $67.40 and a 1-year high of $89.69. The stock has a market cap of $72.30 billion, a price-to-earnings ratio of 17.06 and a beta of 1.25. The firm has a 50-day moving average of $78.27 and a 200 day moving average of $80.63.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock repurchase program on Thursday, June 29th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: “Nikko Asset Management Americas Inc. Has $157,000 Stake in Walgreens Boots Alliance, Inc. (WBA)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/10/15/nikko-asset-management-americas-inc-has-157000-stake-in-walgreens-boots-alliance-inc-wba.html.

A number of analysts have commented on WBA shares. Loop Capital assumed coverage on shares of Walgreens Boots Alliance in a research report on Thursday, August 24th. They set a “buy” rating and a $95.00 price target on the stock. Needham & Company LLC reissued a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Finally, Credit Suisse Group reissued a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $90.18.

In other news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.